Lawrence R. Evans - May 18, 2022 Form 3 Insider Report for DAVEY TREE EXPERT CO (NONE)

Role
EVP & GM, Surgery Company
Signature
/s/Lawrence R. Evans, Christopher J. Bast by Power of Attorney
Stock symbol
NONE
Transactions as of
May 18, 2022
Transactions value $
$0
Form type
3
Date filed
5/20/2022, 10:45 AM
Next filing
Jul 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NONE Common Stock 208K May 18, 2022 Direct
holding NONE Common Stock 33.7K May 18, 2022 By 401KSOP F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NONE Non-Qualified Stock Option (Right to Buy) May 18, 2022 Common Stock 4K $8.18 Direct F2
holding NONE Non-Qualified Stock Option (Right to Buy) May 18, 2022 Common Stock 3K $8.80 Direct F2
holding NONE Non-Qualified Stock Option (Right to Buy) May 18, 2022 Common Stock 3.4K $9.55 Direct F2
holding NONE Non-Qualified Stock Option (Right to Buy) May 18, 2022 Common Stock 3.63K $10.55 Direct F2
holding NONE Non-Qualified Stock Option (Right to Buy) May 18, 2022 Common Stock 4K $12.10 Direct F2
holding NONE Stock Appreciation Rights (2013) May 18, 2022 Common Stock 4.8K $5.80 Direct F3
holding NONE Stock Appreciation Rights (2014) May 18, 2022 Common Stock 5K $6.60 Direct F3
holding NONE Stock Appreciation Rights (2015) May 18, 2022 Common Stock 5K $7.53 Direct F3
holding NONE Stock Appreciation Rights (2016) May 18, 2022 Common Stock 8.4K $8.18 Direct F3
holding NONE Stock Appreciation Rights (2017) May 18, 2022 Common Stock 4.4K $8.80 Direct F3
holding NONE Stock Appreciation Rights (2018) May 18, 2022 Common Stock 8.64K $9.55 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This total reflects routine accumulation of 33,700.2210 common shares acquired through the Company's 401(K) benefit plan as of May 18, 2022, based on internal records.
F2 These options vest and become exercisable in five equal annual installments beginning on the first anniversary of the grant date.
F3 These stock appreciation rights become exercisable in five equal annual installments beginning on the first anniversary of the grant date.